Detalhe da pesquisa
1.
Genetic testing in prostate cancer management: Considerations informing primary care.
CA Cancer J Clin
; 72(4): 360-371, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201622
2.
Can MRI Help Inform Which Men With a History of Multifocal High-Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?
J Urol
; 211(2): 234-240, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37930976
3.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
J Urol
; 211(4): 526-532, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421252
4.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy.
J Urol
; 211(4): 509-517, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421253
5.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
J Urol
; 211(4): 518-525, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421243
6.
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Proc Natl Acad Sci U S A
; 118(24)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099557
7.
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.
J Urol
; 210(5): 771-777, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566643
8.
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
J Urol
; 209(5): 882-889, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795962
9.
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.
Nutr Cancer
; 75(2): 618-626, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343223
10.
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Cancer
; 128(2): 269-274, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516660
11.
Federal Oversight of Laboratory-Developed Tests. Reply.
N Engl J Med
; 390(5): 483-484, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294994
12.
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
J Urol
; 207(4): 805-813, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854745
13.
Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.
J Urol
; 208(5): 1007-1017, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930793
14.
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
J Urol
; 208(5): 1037-1045, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830553
15.
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
BMC Cancer
; 22(1): 494, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513774
16.
Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes.
World J Urol
; 40(1): 35-42, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655428
17.
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol
; 40(11): 2707-2715, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169695
18.
Delayed urologic cancer care in the COVID-19 pandemic: Patients' experiences.
Eur J Cancer Care (Engl)
; 31(6): e13677, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942930
19.
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.
Lancet Oncol
; 22(3): 402-410, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662287
20.
Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis.
Cancer Sci
; 112(2): 859-870, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33232539